Comprehensive quantitative analysis of ovarian and breast cancer tumor peptidomes

Journal of Proteome Research

Volumn 14, Issue 1, 2015, Pages 422-433

  Xu, Zhe ^a   Wu, Chaochao ^a   Xie, Fang ^a   Slysz, Gordon W ^a   Tolic, Nikola ^b   Monroe, Matthew E ^a   Petyuk, Vladislav A ^a   Payne, Samuel H ^a   Fujimoto, Grant M ^a   Moore, Ronald J ^a   Fillmore, Thomas L ^b   Schepmoes, Athena A ^a   Levine, Douglas A ^c   Townsend, R Reid ^d   Davies, Sherri R ^d   Li, Shunqiang ^d   Ellis, Matthew ^d   Boja, Emily ^e   Rivers, Robert ^e   Rodriguez, Henry ^e   Rodland, Karin D ^a   Liu, Tao ^a   Smith, Richard D ^a   more..

^a PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

breast cancer; ischemia; ovarian cancer; peptidomics; proteases; protein degradation; tumor

Indexed keywords

BIOLOGICAL MARKER; PEPTIDE; PROTEOME;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; FEMALE; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; MASS SPECTROMETRY; OVARY CANCER; PEPTIDOMICS; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; QUANTITATIVE STUDY; XENOGRAFT; BREAST TUMOR; GENE EXPRESSION REGULATION; GENETICS; LIQUID CHROMATOGRAPHY; METABOLISM; OVARY TUMOR; PROCEDURES; PROTEOMICS; TANDEM MASS SPECTROMETRY; TIME;

BREAST NEOPLASMS; CHROMATOGRAPHY, LIQUID; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OVARIAN NEOPLASMS; PEPTIDES; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY; TIME FACTORS;

EID: 84920266257     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr500840w     Document Type: Article

References (52)

1. Kondakova, I. V.; Spirina, L. V.; Shashova, E. E.; Koval, V. D.; Kolomiets, L. A.; Chernysheva, A. L.; Slonimskaia, E. M. Proteasome activity in tumors of female reproductive system Bioorg. Khim. 2012, 38 (1) 106-110
2. Willumsen, N.; Bager, C. L.; Leeming, D. J.; Smith, V.; Karsdal, M. A.; Dornan, D.; Bay-Jensen, A. C. Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls BMC Cancer 2013, 13 (1) 554
3. Villanueva, J.; Shaffer, D. R.; Philip, J.; Chaparro, C. A.; Erdjument-Bromage, H.; Olshen, A. B.; Fleisher, M.; Lilja, H.; Brogi, E.; Boyd, J.; Sanchez-Carbayo, M.; Holland, E. C.; Cordon-Cardo, C.; Scher, H. I.; Tempst, P. Differential exoprotease activities confer tumor-specific serum peptidome patterns J. Clin. Invest. 2006, 116 (1) 271-284
4. Lopez-Otin, C.; Overall, C. M. Protease degradomics: a new challenge for proteomics Nat. Rev. Mol. Cell Biol. 2002, 3 (7) 509-519
5. Gelman, J. S.; Sironi, J.; Castro, L. M.; Ferro, E. S.; Fricker, L. D. Peptidomic analysis of human cell lines J. Proteome Res. 2011, 10 (4) 1583-1592
6. Fricker, L. D.; Gelman, J. S.; Castro, L. M.; Gozzo, F. C.; Ferro, E. S. Peptidomic analysis of HEK293T cells: effect of the proteasome inhibitor epoxomicin on intracellular peptides J. Proteome Res. 2012, 11 (3) 1981-1990
7. Marshall, J.; Kupchak, P.; Zhu, W.; Yantha, J.; Vrees, T.; Furesz, S.; Jacks, K.; Smith, C.; Kireeva, I.; Zhang, R.; Takahashi, M.; Stanton, E.; Jackowski, G. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction J. Proteome Res. 2003, 2 (4) 361-372
8. Zhang, Z.; Bast, R. C.; Yu, Y. H.; Li, J. N.; Sokoll, L. J.; Rai, A. J.; Rosenzweig, J. M.; Cameron, B.; Wang, Y. Y.; Meng, X. Y.; Berchuck, A.; van Haaften-Day, C.; Hacker, N. F.; de Bruijn, H. W. A.; van der Zee, A. G. J.; Jacobs, I. J.; Fung, E. T.; Chan, D. W. Three biomarkers identified from serum proteomic analysis for the detection of early stage ovarian cancer Cancer Res. 2004, 64 (16) 5882-5890
9. Koomen, J. M.; Li, D. H.; Xiao, L. C.; Liu, T. C.; Coombes, K. R.; Abbruzzese, J.; Kobayashi, R. Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery J. Proteome Res. 2005, 4 (3) 972-981
10. Jurgens, M.; Appel, A.; Heine, G.; Neitz, S.; Menzel, C.; Tammen, H.; Zucht, H. D. Towards characterization of the human urinary peptidome Comb. Chem. High Throughput Screening 2005, 8 (8) 757-765
11. Fiedler, G. M.; Baumann, S.; Leichtle, A.; Oltmann, A.; Kase, J.; Thiery, J.; Ceglarek, U. Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry Clin. Chem. 2007, 53 (3) 421-428
12. Strand, F. L. Neuropeptides: general characteristics and neuropharmaceutical potential in treating CNS disorders Prog. Drug Res. 2003, 61, 1-37
13. Hummon, A. B.; Amare, A.; Sweedler, J. V. Discovering new invertebrate neuropeptides using mass spectrometry Mass Spectrom Rev. 2006, 25 (1) 77-98
14. Yatskin, O. N.; Karelin, A. A.; Ivanov, V. T. Peptidomes of the brain, heart, lung, and spleen of a rat: similarity and differences Russ. J. Bioorg. Chem. 2009, 35 (4) 426-436
15. Lassout, O.; Pastor, C. M.; Fetaud-Lapierre, V.; Hochstrasser, D. F.; Frossard, J. L.; Lescuyer, P. Analysis of the pancreatic low molecular weight proteome in an animal model of acute pancreatitis J. Proteome Res. 2010, 9 (9) 4535-4544
16. Alvarez, M. T. B.; Shah, D. J.; Thulin, C. D.; Graves, S. W. Tissue proteomics of the low-molecular weight proteome using an integrated cLC-ESI-QTOFMS approach Proteomics 2013, 13 (9) 1400-1411
17. Cunha, F. M.; Berti, D. A.; Ferreira, Z. S.; Klitzke, C. F.; Markus, R. P.; Ferro, E. S. Intracellular peptides as natural regulators of cell signaling J. Biol. Chem. 2008, 283 (36) 24448-24459
18. Shen, Y.; Tolic, N.; Liu, T.; Zhao, R.; Petritis, B. O.; Gritsenko, M. A.; Camp, D. G.; Moore, R. J.; Purvine, S. O.; Esteva, F. J.; Smith, R. D. Blood peptidome-degradome profile of breast cancer PLoS One 2010, 5 (10) e13133
19. de Bruin, J. S.; Deelder, A. M.; Palmblad, M. Scientific workflow management in proteomics Mol. Cell. Proteomics 2012, 11 (7) M111.010595
20. Zhu, X.; Desiderio, D. M. Methionine enkephalin-like immunoreactivity, substance P-like immunoreactivity and beta-endorphin-like immunoreactivity post-mortem stability in rat pituitary J. Chromatogr. 1993, 616 (2) 175-187
21. Shahinian, H.; Loessner, D.; Biniossek, M. L.; Kizhakkedathu, J. N.; Clements, J. A.; Magdolen, V.; Schilling, O. Secretome and degradome profiling shows that Kallikrein-related peptidases 4, 5, 6, and 7 induce TGFβ-1 signaling in ovarian cancer cells Mol. Oncol. 2014, 8 (1) 68-82
22. Li, S.; Shen, D.; Shao, J.; Crowder, R.; Liu, W.; Prat, A.; He, X.; Liu, S.; Hoog, J.; Lu, C.; Ding, L.; Griffith, O. L.; Miller, C.; Larson, D.; Fulton, R. S.; Harrison, M.; Mooney, T.; McMichael, J. F.; Luo, J.; Tao, Y.; Goncalves, R.; Schlosberg, C.; Hiken, J. F.; Saied, L.; Sanchez, C.; Giuntoli, T.; Bumb, C.; Cooper, C.; Kitchens, R. T.; Lin, A.; Phommaly, C.; Davies, S. R.; Zhang, J.; Kavuri, M. S.; McEachern, D.; Dong, Y. Y.; Ma, C.; Pluard, T.; Naughton, M.; Bose, R.; Suresh, R.; McDowell, R.; Michel, L.; Aft, R.; Gillanders, W.; DeSchryver, K.; Wilson, R. K.; Wang, S.; Mills, G. B.; Gonzalez-Angulo, A.; Edwards, J. R.; Maher, C.; Perou, C. M.; Mardis, E. R.; Ellis, M. J. Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts Cell Rep. 2013, 4 (6) 1116-1130
23. Ding, L.; Ellis, M. J.; Li, S.; Larson, D. E.; Chen, K.; Wallis, J. W.; Harris, C. C.; McLellan, M. D.; Fulton, R. S.; Fulton, L. L.; Abbott, R. M.; Hoog, J.; Dooling, D. J.; Koboldt, D. C.; Schmidt, H.; Kalicki, J.; Zhang, Q.; Chen, L.; Lin, L.; Wendl, M. C.; McMichael, J. F.; Magrini, V. J.; Cook, L.; McGrath, S. D.; Vickery, T. L.; Appelbaum, E.; Deschryver, K.; Davies, S.; Guintoli, T.; Lin, L.; Crowder, R.; Tao, Y.; Snider, J. E.; Smith, S. M.; Dukes, A. F.; Sanderson, G. E.; Pohl, C. S.; Delehaunty, K. D.; Fronick, C. C.; Pape, K. A.; Reed, J. S.; Robinson, J. S.; Hodges, J. S.; Schierding, W.; Dees, N. D.; Shen, D.; Locke, D. P.; Wiechert, M. E.; Eldred, J. M.; Peck, J. B.; Oberkfell, B. J.; Lolofie, J. T.; Du, F.; Hawkins, A. E.; O'Laughlin, M. D.; Bernard, K. E.; Cunningham, M.; Elliott, G.; Mason, M. D.; Thompson, D. M., Jr.; Ivanovich, J. L.; Goodfellow, P. J.; Perou, C. M.; Weinstock, G. M.; Aft, R.; Watson, M.; Ley, T. J.; Wilson, R. K.; Mardis, E. R. Genome remodelling in a basal-like breast cancer metastasis and xenograft Nature 2010, 464 (7291) 999-1005
24. Eng, J. K.; McCormack, A. L.; Yates, J. R. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database J. Am. Soc. Mass Spectrom. 1994, 5 (11) 976-989
25. Kim, S.; Gupta, N.; Pevzner, P. A. Spectral probabilities and generating functions of tandem mass spectra: a strike against decoy databases J. Proteome Res. 2008, 7 (8) 3354-3363
26. Liu, X.; Sirotkin, Y.; Shen, Y.; Anderson, G.; Tsai, Y. S.; Ting, Y. S.; Goodlett, D. R.; Smith, R. D.; Bafna, V.; Pevzner, P. A. Protein identification using top-down Mol. Cell. Proteomics 2012, 11 (6) M111.008524
27. Shen, Y.; Liu, T.; Tolic, N.; Petritis, B. O.; Zhao, R.; Moore, R. J.; Purvine, S. O.; Camp, D. G.; Smith, R. D. Strategy for degradomic-peptidomic analysis of human blood plasma J. Proteome Res. 2010, 9 (5) 2339-2346
28. Jaitly, N.; Mayampurath, A.; Littlefield, K.; Adkins, J. N.; Anderson, G. A.; Smith, R. D. Decon2LS: an open-source software package for automated processing and visualization of high resolution mass spectrometry data BMC Bioinf. 2009, 10, 87
29. Monroe, M. E.; Tolic, N.; Jaitly, N.; Shaw, J. L.; Adkins, J. N.; Smith, R. D. VIPER: an advanced software package to support high-throughput LC-MS peptide identification Bioinformatics 2007, 23 (15) 2021-2023
30. Slysz, G. W.; Steinke, L.; Ward, D. M.; Klatt, C. G.; Clauss, T. R.; Purvine, S. O.; Payne, S. H.; Anderson, G. A.; Smith, R. D.; Lipton, M. S. Automated data extraction from in situ protein-stable isotope probing studies J. Proteome Res. 2014, 13 (3) 1200-1210
31. Holman, J. D.; Ma, Z. Q.; Tabb, D. L. Identifying proteomic LC-MS/MS data sets with Bumbershoot and IDPicker. Current Protocols in Bioinformatics; Wiley Online Library: New York, 2012; Chapter 13, Unit 13.17.
32. Taverner, T.; Karpievitch, Y. V.; Polpitiya, A. D.; Brown, J. N.; Dabney, A. R.; Anderson, G. A.; Smith, R. D. DanteR: an extensible R-based tool for quantitative analysis of -omics data Bioinformatics 2012, 28 (18) 2404-2406
33. Schechter, I.; Berger, A. On the active site of proteases. 3. Mapping the active site of papain; specific peptide inhibitors of papain Biochem. Biophys. Res. Commun. 1968, 32 (5) 898-902
34. Smyth, G. K. Linear models and empirical bayes methods for assessing differential expression in microarray experiments Stat. Appl. Genet. Mol. Biol. 2004, 3, 3
35. Mertins, P.; Yang, F.; Liu, T.; Mani, D. R.; Petyuk, V. A.; Gillette, M. A.; Clauser, K. R.; Qiao, J. W.; Gritsenko, M. A.; Moore, R. J.; Levine, D. A.; Townsend, R.; Erdmann-Gilmore, P.; Snider, J. E.; Davies, S. A.; Ruggles, K. V.; Fenyo, D.; Kitchens, R. T.; Li, S.; Olvera, N.; Dao, F.; Rodriguez, H.; Chan, D. W.; Liebler, D.; White, F.; Rodland, K. D.; Mills, G. B.; Smith, R. D.; Paulovich, A. G.; Ellis, M.; Carr, S. A. Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels Mol. Cell. Proteomics 2014, 13 (7) 1690-1704
36. Smith, R. D.; Anderson, G. A.; Lipton, M. S.; Pasa-Tolic, L.; Shen, Y.; Conrads, T. P.; Veenstra, T. D.; Udseth, H. R. An accurate mass tag strategy for quantitative and high-throughput proteome measurements Proteomics 2002, 2 (5) 513-523
37. Zimmer, J. S.; Monroe, M. E.; Qian, W. J.; Smith, R. D. Advances in proteomics data analysis and display using an accurate mass and time tag approach Mass Spectrom. Rev. 2006, 25 (3) 450-482
38. Keil, B. Specificity of Proteolysis; Springer-Verlag: Berlin, 1992.
39. Nixon, R. A.; Saito, K. I.; Grynspan, F.; Griffin, W. R.; Katayama, S.; Honda, T.; Mohan, P. S.; Shea, T. B.; Beermann, M. Calcium-activated neutral proteinase (calpain) system in aging and Alzheimer's disease Ann. N.Y. Acad. Sci. 1994, 747, 77-91
40. Wenzel, T.; Eckerskorn, C.; Lottspeich, F.; Baumeister, W. Existence of a molecular ruler in proteasomes suggested by analysis of degradation products FEBS Lett. 1994, 349 (2) 205-209
41. Glickman, M. H.; Ciechanover, A. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction Physiol. Rev. 2002, 82 (2) 373-428
42. Van Damme, P.; Maurer-Stroh, S.; Plasman, K.; Van Durme, J.; Colaert, N.; Timmerman, E.; De Bock, P. J.; Goethals, M.; Rousseau, F.; Schymkowitz, J.; Vandekerckhove, J.; Gevaert, K. Analysis of protein processing by N-terminal proteomics reveals novel species-specific substrate determinants of granzyme B orthologs Mol. Cell. Proteomics 2009, 8 (2) 258-272
43. Dick, T. P.; Nussbaum, A. K.; Deeg, M.; Heinemeyer, W.; Groll, M.; Schirle, M.; Keilholz, W.; Stevanovic, S.; Wolf, D. H.; Huber, R.; Rammensee, H. G.; Schild, H. Contribution of proteasomal beta-subunits to the cleavage of peptide substrates analyzed with yeast mutants J. Biol. Chem. 1998, 273 (40) 25637-25646
44. Doherty, M. K.; Hammond, D. E.; Clague, M. J.; Gaskell, S. J.; Beynon, R. J. Turnover of the human proteome: determination of protein intracellular stability by dynamic SILAC J. Proteome Res. 2009, 8 (1) 104-112
45. Boisvert, F. M.; Ahmad, Y.; Gierlinski, M.; Charriere, F.; Lamont, D.; Scott, M.; Barton, G.; Lamond, A. I. A quantitative spatial proteomics analysis of proteome turnover in human cells Mol. Cell. Proteomics 2012, 11 (3) M111.011429
46. Fricker, L. D.; Lim, J.; Pan, H.; Che, F. Y. Peptidomics: identification and quantification of endogenous peptides in neuroendocrine tissues Mass Spectrom. Rev. 2006, 25 (2) 327-344
47. Leichtle, A. B.; Dufour, J. F.; Fiedler, G. M. Potentials and pitfalls of clinical peptidomics and metabolomics Swiss Med. Wkly. 2013, 143, w13801
48. Voges, D.; Zwickl, P.; Baumeister, W. The 26S proteasome: a molecular machine designed for controlled proteolysis Annu. Rev. Biochem. 1999, 68, 1015-1068
49. Zwickl, P.; Voges, D.; Baumeister, W. The proteasome: a macromolecular assembly designed for controlled proteolysis Philos. Trans. R Soc. London, Ser. B 1999, 354 (1389) 1501-1511
50. Sherman, F.; Stewart, J. W.; Tsunasawa, S. Methionine or not methionine at the beginning of a protein Bioessays 1985, 3 (1) 27-31
51. Varshavsky, A. The N-end rule: functions, mysteries, uses Proc. Natl. Acad. Sci. U.S.A. 1996, 93 (22) 12142-12149
52. Giglione, C.; Boularot, A.; Meinnel, T. Protein N-terminal methionine excision Cell. Mol. Life Sci. 2004, 61 (12) 1455-1474